Global Natural Killer (NK) Cell Therapeutics Market Growth 2018-2023

Publisher Name :
Date: 22-Oct-2018
No. of pages: 136

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Natural Killer (NK) Cell Therapeutics market for 2018-2023.

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.

Over the next five years, LPI(LP Information) projects that Natural Killer (NK) Cell Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer (NK) Cell Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Mogamulizumab

- Lorvotuzumab Mertansine

- Others

Segmentation by application:

- Cancer

- Cardiovascular Diseases

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Chipscreen Biosciences (China)

- Affimed NV (Netherlands)

- Altor BioScience Corporation (USA)

- Innate Pharma SA (France)

- Takeda Pharmaceutical (Japan)

- Sorrento Therapeutics Inc. (USA)

- NantKwest Inc. (USA)

- Bristol-Myers Squibb (USA)

- NKT Therapeutics (USA)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Natural Killer (NK) Cell Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Natural Killer (NK) Cell Therapeutics market by identifying its various subsegments.

- Focuses on the key global Natural Killer (NK) Cell Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Natural Killer (NK) Cell Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Natural Killer (NK) Cell Therapeutics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Natural Killer (NK) Cell Therapeutics Market Growth 2018-2023

Table of Contents

2018-2023 Global Natural Killer (NK) Cell Therapeutics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Natural Killer (NK) Cell Therapeutics Consumption 2013-2023
2.1.2 Natural Killer (NK) Cell Therapeutics Consumption CAGR by Region
2.2 Natural Killer (NK) Cell Therapeutics Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 Natural Killer (NK) Cell Therapeutics Consumption by Type
2.3.1 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Type (2013-2018)
2.4 Natural Killer (NK) Cell Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 Natural Killer (NK) Cell Therapeutics Consumption by Application
2.5.1 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Natural Killer (NK) Cell Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Application (2013-2018)

3 Global Natural Killer (NK) Cell Therapeutics by Players
3.1 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players
3.1.1 Global Natural Killer (NK) Cell Therapeutics Sales by Players (2016-2018)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players
3.2.1 Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Players
3.4 Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Natural Killer (NK) Cell Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Natural Killer (NK) Cell Therapeutics by Regions
4.1 Natural Killer (NK) Cell Therapeutics by Regions
4.1.1 Global Natural Killer (NK) Cell Therapeutics Consumption by Regions
4.1.2 Global Natural Killer (NK) Cell Therapeutics Value by Regions
4.2 Americas Natural Killer (NK) Cell Therapeutics Consumption Growth
4.3 APAC Natural Killer (NK) Cell Therapeutics Consumption Growth
4.4 Europe Natural Killer (NK) Cell Therapeutics Consumption Growth
4.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Growth

5 Americas
5.1 Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries
5.1.1 Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
5.2 Americas Natural Killer (NK) Cell Therapeutics Consumption by Type
5.3 Americas Natural Killer (NK) Cell Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries
6.1.1 APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
6.2 APAC Natural Killer (NK) Cell Therapeutics Consumption by Type
6.3 APAC Natural Killer (NK) Cell Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics by Countries
7.1.1 Europe Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
7.2 Europe Natural Killer (NK) Cell Therapeutics Consumption by Type
7.3 Europe Natural Killer (NK) Cell Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics by Countries
8.1.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Type
8.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Natural Killer (NK) Cell Therapeutics Distributors
10.3 Natural Killer (NK) Cell Therapeutics Customer

11 Global Natural Killer (NK) Cell Therapeutics Market Forecast
11.1 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast (2018-2023)
11.2 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions
11.2.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Natural Killer (NK) Cell Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Natural Killer (NK) Cell Therapeutics Forecast by Type
11.8 Global Natural Killer (NK) Cell Therapeutics Forecast by Application

12 Key Players Analysis
12.1 Chipscreen Biosciences (China)
12.1.1 Company Details
12.1.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Chipscreen Biosciences (China) News
12.2 Affimed NV (Netherlands)
12.2.1 Company Details
12.2.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Affimed NV (Netherlands) News
12.3 Altor BioScience Corporation (USA)
12.3.1 Company Details
12.3.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Altor BioScience Corporation (USA) News
12.4 Innate Pharma SA (France)
12.4.1 Company Details
12.4.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Innate Pharma SA (France) News
12.5 Takeda Pharmaceutical (Japan)
12.5.1 Company Details
12.5.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Takeda Pharmaceutical (Japan) News
12.6 Sorrento Therapeutics Inc. (USA)
12.6.1 Company Details
12.6.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sorrento Therapeutics Inc. (USA) News
12.7 NantKwest Inc. (USA)
12.7.1 Company Details
12.7.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 NantKwest Inc. (USA) News
12.8 Bristol-Myers Squibb (USA)
12.8.1 Company Details
12.8.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Bristol-Myers Squibb (USA) News
12.9 NKT Therapeutics (USA)
12.9.1 Company Details
12.9.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 NKT Therapeutics (USA) News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Natural Killer (NK) Cell Therapeutics
Table Product Specifications of Natural Killer (NK) Cell Therapeutics
Figure Natural Killer (NK) Cell Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Natural Killer (NK) Cell Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Mogamulizumab
Table Major Players of Mogamulizumab
Figure Product Picture of Lorvotuzumab Mertansine
Table Major Players of Lorvotuzumab Mertansine
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Type (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Type (2013-2018)
Figure Natural Killer (NK) Cell Therapeutics Consumed in Cancer
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2013-2018) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2013-2018) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure Natural Killer (NK) Cell Therapeutics Consumed in Cardiovascular Diseases
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2013-2018) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2013-2018) ($ Millions)
Figure Global Cardiovascular Diseases YoY Growth ($ Millions)
Figure Natural Killer (NK) Cell Therapeutics Consumed in Others
Figure Global Natural Killer (NK) Cell Therapeutics Market: Others (2013-2018) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Value by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Application (2013-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players in 2016
Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players in 2017
Table Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players in 2016
Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players in 2017
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Players (2016-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Sale Price by Players in 2017
Table Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Natural Killer (NK) Cell Therapeutics Products Offered
Table Natural Killer (NK) Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Natural Killer (NK) Cell Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Natural Killer (NK) Cell Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Regions 2013-2018
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table Americas Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure United States Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table APAC Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure China Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table Europe Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table Natural Killer (NK) Cell Therapeutics Distributors List
Table Natural Killer (NK) Cell Therapeutics Customer List
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Forecast by Regions
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Regions
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure United States Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure United States Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure China Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure China Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure India Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure India Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure France Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure France Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure UK Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure UK Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Chipscreen Biosciences (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Affimed NV (Netherlands) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Altor BioScience Corporation (USA) Basic Infor
  • Global Nanostructured Drug Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Nanostructured Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nanostructured Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nanostructured Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumpt......
  • Global Silicone Foley Catheter Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Silicone Foley Catheter market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Silicone Foley Catheter volume and value at global level, regional level and company level. From a global perspective, this report represents overall Silicone Foley Catheter market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, appar......
  • Global Breast Cancer Therapeutics Drugs Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Breast Cancer Therapeutics Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Breast Cancer Therapeutics Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Breast Cancer Therapeutics Drugs market size by analyzing historical data and future prospect. Regionally, this report catego......
  • Global CD14 (Antibody) Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global CD14(Antibody) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on CD14(Antibody) volume and value at global level, regional level and company level. From a global perspective, this report represents overall CD14(Antibody) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and......
  • Global Rare Disease Drug Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 127
    The global Rare Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rare Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rare Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, e......
  • Global Ubiquitin Enzymes Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global Ubiquitin Enzymes market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ubiquitin Enzymes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ubiquitin Enzymes market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, e......
  • Global HS3S1 Antibody Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global HS3S1 Antibody market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on HS3S1 Antibody volume and value at global level, regional level and company level. From a global perspective, this report represents overall HS3S1 Antibody market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and......
  • Global CASP7 Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global CASP7 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on CASP7 volume and value at global level, regional level and company level. From a global perspective, this report represents overall CASP7 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of CASP7 in North A......
  • Global Pneumococcal Vaccines Market Professional Survey Report 2019
    Published: 06-Dec-2019        Price: US 3500 Onwards        Pages: 126
    The global Pneumococcal Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pneumococcal Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Vaccines market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs